ACUTE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS WITH METHOTREXATE AND CYCLOSPORINE AFTER BUSULFAN AND CYCLOPHOSPHAMIDE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

被引：0
|
作者：
VONBUELTZINGSLOEWEN, A
BELANGER, R
PERREAULT, C
BONNY, Y
ROY, DC
LALONDE, Y
BOILEAU, J
KASSIS, J
LAVALLEE, R
LACOMBE, M
GYGER, M
机构：
[1] UNIV MONTREAL, HOP MAISONNEUVE ROSEMONT, DEPT HEMATOL, 5415 ASSOMPT BLVD, MONTREAL H1T 2M4, PQ, CANADA
[2] UNIV MONTREAL, HOP MAISONNEUVE ROSEMONT, UNITE TRANSPLANTAT MOELLE OSSEUSE, MONTREAL H1T 2M4, PQ, CANADA
来源：
BLOOD | 1993年 / 81卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：849 / 855
页数：7
相关论文
共 50 条
  • [21] Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease
    Laverdiere, Isabelle
    Guillemette, Chantal
    Tamouza, Ryad
    Loiseau, Pascale
    de latour, Regis Peffault
    Robin, Marie
    Couture, Felix
    Filion, Alain
    Lalancette, Marc
    Tourancheau, Alan
    Charron, Dominique
    Socie, Gerard
    Levesque, Eric
    HAEMATOLOGICA, 2015, 100 (02) : 275 - 283
  • [22] Prophylaxis of graft-versus-host disease with cyclosporine–prednisone is associated with increased risk of chronic graft-versus-host disease
    S Kumar
    MG Chen
    DA Gastineau
    MA Gertz
    DJ Inwards
    MQ Lacy
    A Tefferi
    WS Harmsen
    MR Litzow
    Bone Marrow Transplantation, 2001, 27 : 1133 - 1140
  • [23] Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
    Ardizzoia, Federica
    Lorentino, Francesca
    Bruno, Alessandro
    Marktel, Sarah
    Giglio, Fabio
    Clerici, Daniela
    Farina, Francesca
    Mastaglio, Sara
    Piemontese, Simona
    Assanelli, Andrea A.
    Carrabba, Matteo G.
    Bernardi, Massimo
    Corti, Consuelo
    Peccatori, Jacopo
    Ciceri, Fabio
    Greco, Raffaella
    Lupo-Stanghellini, Maria Teresa
    HAEMATOLOGICA, 2022, 107 : 2748 - 2751
  • [24] Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
    Ardizzoia, Federica
    Lorentino, Francesca
    Bruno, Alessandro
    Marktel, Sarah
    Giglio, Fabio
    Clerici, Daniela
    Farina, Francesca
    Mastaglio, Sara
    Piemontese, Simona
    Assanelli, Andrea A.
    Carrabba, Matteo G.
    Bernardi, Massimo
    Corti, Consuelo
    Peccatori, Jacopo
    Ciceri, Fabio
    Greco, Raffaella
    Lupo-Stanghellini, Maria Teresa
    HAEMATOLOGICA, 2022, 107 (11) : 2748 - 2751
  • [25] CYCLOSPORINE-A VERSUS METHOTREXATE, FOLLOWED BY RESCUE WITH FOLINIC ACID AS PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION
    TORRES, A
    MARTINEZ, F
    GOMEZ, P
    HERRERA, C
    ROJAS, R
    GOMEZVILLAGRAN, JL
    GARCIACASTELLANO, JM
    VELASCO, F
    ANDRES, P
    FORNES, G
    MANZANARES, R
    BLUT, 1989, 58 (02): : 63 - 68
  • [26] Tacrolimus versus cyclosporine A in prophylaxis of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in patients with acute leukaemia
    Stankevich, Y.
    Zubarovskaya, L.
    Vavilov, V.
    Bondarenko, S.
    Darskaya, E.
    Kulagin, A.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S153 - S154
  • [27] Post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in pediatric patients with hematologic malignancies transplanted from haploidentical and matched unrelated donors
    Abrosimov, A.
    Shelikhova, L.
    Shekhovtsova, Z.
    Skvortsova, J.
    Muzalevsky, I.
    Kazachenok, A.
    Ilushina, M.
    Shipitsina, I.
    Shasheleva, D.
    Khismatullina, R.
    Blagov, S.
    Gutovskaya, E.
    Myakova, N.
    Litvinov, D.
    Novichkova, G.
    Maschan, A.
    Maschan, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S460 - S460
  • [28] POST-TRANSPLANT CYCLOPHOSPHAMIDE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN PEDIATRIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES TRANSPLANTED FROM HAPLOIDENTICAL AND MATCHED UNRELATED DONORS
    Abrosimov, A.
    Shelikhova, L.
    Shekhovtsova, Z.
    Balashov, D.
    Skvortsova, Y.
    Kurnikova, E.
    Ilushina, M.
    Shipitsina, I.
    Shasheleva, D.
    Khismatullina, R.
    Gutovskaya, E.
    Blagov, S.
    Myakova, N.
    Litvinov, D.
    Baidildina, D.
    Novichkova, G.
    Maschan, M.
    Maschan, A.
    HAEMATOLOGICA, 2016, 101 : 636 - 636
  • [29] INCIDENCE OF HYPERTENSION AFTER MARROW TRANSPLANTATION AMONG 112 PATIENTS RANDOMIZED TO EITHER CYCLOSPORINE OR METHOTREXATE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS
    LOUGHRAN, TP
    DEEG, HJ
    DAHLBERG, S
    KENNEDY, MS
    STORB, R
    THOMAS, ED
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 59 (03) : 547 - 553
  • [30] METHOTREXATE AND CYCLOSPORINE COMPARED WITH CYCLOSPORINE ALONE FOR PROPHYLAXIS OF ACUTE GRAFT VERSUS HOST-DISEASE AFTER MARROW TRANSPLANTATION FOR LEUKEMIA
    STORB, R
    DEEG, HJ
    WHITEHEAD, J
    APPELBAUM, F
    BEATTY, P
    BENSINGER, W
    BUCKNER, CD
    CLIFT, R
    DONEY, K
    FAREWELL, V
    HANSEN, J
    HILL, R
    LUM, L
    MARTIN, P
    MCGUFFIN, R
    SANDERS, J
    STEWART, P
    SULLIVAN, K
    WITHERSPOON, R
    YEE, G
    THOMAS, ED
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (12): : 729 - 735
12345